Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons
Antibiotics · 19.06.2023 · 12 (6) · 1074
DOI: 10.3390/antibiotics12061074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 19.06.2023. Verfasst von Natalia Roson-Calero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Barcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the last decades, we have witnessed a steady increase in infections caused by multidrug-resistant (MDR) bacteria. These infections are associated with higher morbidity and mortality. Several interventions should be taken to reduce the emergence and spread of MDR bacteria. The eradication of resistant pathogens colonizing specific human body sites that would likely cause further infection in other sites is one of the most conventional strategies. The objective of this narrative mini-review is to compile and discuss different strategies for the eradication of MDR bacteria from gut microbiota. Here, we analyse the prevalence of MDR bacteria in the community and the hospital and the clinical impact of gut microbiota colonisation with MDR bacteria. Then, several strategies to eliminate MDR bacteria from gut microbiota are described and include: (i) selective decontamination of the digestive tract (SDD) using a cocktail of antibiotics; (ii) the use of pre and probiotics; (iii) fecal microbiota transplantation; (iv) the use of specific phages; (v) engineered CRISPR-Cas Systems. This review intends to provide a state-of-the-art of the most relevant strategies to eradicate MDR bacteria from gut microbiota currently being investigated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barcelona Institute for Global Health (ISGlobal), 08036 Barcelona, Spain.
- Department of Basic Clinical Practice, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III, 28029 Madrid, Spain.
- Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, 08036 Barcelona, Spain.
- European Foundation for the Study of Chronic Liver Failure (EF-Clif), 08021 Barcelona, Spain.
- Department of Clinical Microbiology, Biomedical Diagnostic Center, Hospital Clinic, 08036 Barcelona, Spain.
ORCID-Profile: Natalia Roson-Calero, Clara Ballesté-Delpierre, Jordi Vila
Zitieren
APA
Roson-Calero, N., Ballesté-Delpierre, C., Fernández, J., & Vila, J. (2023). Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons. Antibiotics, 12(6), 1074. https://doi.org/10.3390/antibiotics12061074
Vancouver
Roson-Calero N, Ballesté-Delpierre C, Fernández J, Vila J. Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons. Antibiotics. 2023;12(6):1074. doi:10.3390/antibiotics12061074
BibTeX
@article{RosonCalero2023,
author = {Roson-Calero, Natalia and Ballesté-Delpierre, Clara and Fernández, Javier and Vila, Jordi},
title = {Insights on Current Strategies to Decolonize the Gut from Multidrug-Resistant Bacteria: Pros and Cons},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {6},
pages = {1074},
doi = {10.3390/antibiotics12061074}
}
EUVIMED